Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- Long-Term Follow-Up Protocol for Subjects Treated With Car T Cells No ClinicalTrials.gov identifier reported
- Long-Term Follow-up Protocol for Subjects Treated With JCAR015 No ClinicalTrials.gov identifier reported
- Long-Term Follow-up Protocol for Subjects Treated With JCAR015 (15002) No ClinicalTrials.gov identifier reported
- Longterm Followup Safety and Efficacy Study in Participants With Duchenne Muscular Dystrophy Who Have Received Fordadistrogene Movaparvovec in A Preceding Clinical Study No ClinicalTrials.gov identifier reported
- Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells No ClinicalTrials.gov identifier reported
- Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial No ClinicalTrials.gov identifier reported
- Long-term follow-up study of patients who have previously been exposed to UCART19 allogeneic engineered T-cells expressing a lentiviral-based anti-CD19 chimeric antigen receptor NCT02735083
- Long-Term Follow-Up Study of Patients Who Have Previously Been Exposed to Ucart19 (Allogeneic Engineered T-Cells Expressing A Lentiviral-Based Anti-Cd19 Chimeric Antigen Receptor) NCT02735083
- Long Term Follow Up Study of Patients With Covid 19 Associated Pneumonia Who Participated in A Desig No ClinicalTrials.gov identifier reported
- Long Term Follow Up Study of Patients With Spinal Muscular Atrophy Receiving Risdiplam Treatment No ClinicalTrials.gov identifier reported
- Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy No ClinicalTrials.gov identifier reported
- Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy NCT03999801
- Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy (RGX-314 SRLTFU) No ClinicalTrials.gov identifier reported
- Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination No ClinicalTrials.gov identifier reported
- Long Term Follow Up Study to Monitor the Growth and Development of Pediatric Patients Previously Treated With Everolimus in Study Crad001m2301 Existlt No ClinicalTrials.gov identifier reported
- Long Term follow up with Xofigo No ClinicalTrials.gov identifier reported
- Long-term Health and Economic Benefits of All-Oral HCV Treatment at the VA Year 1 No ClinicalTrials.gov identifier reported
- Long-Term Hemodialysis Catheter No ClinicalTrials.gov identifier reported
- Long-term impact in intensive care survivors of coronavirus disease-19 - the AFTERCOR Study No ClinicalTrials.gov identifier reported
- Long-term impact in intensive care survivors of coronavirus disease-19 - the AFTERCOR Study No ClinicalTrials.gov identifier reported
- Long-term impact of GBCAs on motor and cognitive function following repeated Contrast-Enhanced MRI?ODYSSEY No ClinicalTrials.gov identifier reported
- Long-Term Improvements in Health-Related Quality of Life across Individual DLQI Items for Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol in Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2) No ClinicalTrials.gov identifier reported
- Long-Term Improvements in Health-Related Quality of Life across Individual DLQI Items for Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol in Two Phase 3 Trials CIMPASI-1 and CIMPASI-2 No ClinicalTrials.gov identifier reported
- Long-term improvements in health-related quality of life of patients with moderate to severe plaque psoriasis treated with certolizumab pegol Results from the CIMPASI-1 and CIMPASI-2 phase 3 trials No ClinicalTrials.gov identifier reported
- Long-term improvements in health-related quality of life of patients with moderate to severe plaque psoriasis treated with certolizumab pegol: Results from the CIMPASI-1 and CIMPASI-2 phase 3 trials No ClinicalTrials.gov identifier reported
- Long-Term, Interverntional, Open Label Extension Study Evaluating the Safety of Tocilizumab Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Who Completed the Global, Multinational Trial Wa19977, A 24 Week Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial With A 16 Week Open-Label Lead-In Phase, and 64 Week Open-Label Follow-Up, to Evaluate the Effect on Clinical Response and the Safety of Tocilizumab in Patients With Active Polyarticular-Course Juvenil No ClinicalTrials.gov identifier reported
- Long-Term Maintenance of Vision Required to Drive in Patients With Neovascular Age-Related MacUlar Degeneration Namd and Diabetic MacUlar Edema Dme Following Anti-Vegf Intravitreal Therapy Ivt No ClinicalTrials.gov identifier reported
- Long-term monitoring of frontal plane gait biomechanics following robot assisted or traditional TKA No ClinicalTrials.gov identifier reported
- Longterm Monotherapy Use of Crisaborole No ClinicalTrials.gov identifier reported
- Long Term Natural History of Patients With Severe Or Difficult to Treat Asthma From the Tenor Observational Study No ClinicalTrials.gov identifier reported
- Long Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies No ClinicalTrials.gov identifier reported
- Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies NCT04202341
- Long-term, open-label (dose-blinded), extension study of eptinezumab in children and adolescents with chronic or episodic migraine No ClinicalTrials.gov identifier reported
- Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age NCT02871297
- Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder MDD From 7 to 18 Years of Age NCT02871297
- Long Term Open Label Safety and Efficacy Study of Qge031 in Patients With Chronic Spontaneous Urticaria Csu No ClinicalTrials.gov identifier reported
- Long-Term Open-Label Study to Assess the Safety and Efficacy of Vatiquinone in Patients With Friedreich Ataxia NCT05515536
- Long-Term, Open-Label Study With A Double-Blind, Placebo-Controlled, Randomized Drug Withdrawal Period of Lum001, An Apical Sodium-Dependent Bile Acid Transporter Inhibitor Asbti, in Patients With Alagille Syndrome NCT02160782
- Long term open label treatm. with BI655130 in pat. No ClinicalTrials.gov identifier reported
- Long-Term Outcome of Children Enrolled in Study Ropp-2008-01 Previously Treated With Rhigf-1/Rhigfbp-3 for the Prevention of Retinopathy of Prematurity (Rop) Or Who Received Standard Neonatal Care No ClinicalTrials.gov identifier reported
- Long-Term Outcome of Children Enrolled in Study Ropp-2008-01 Previously Treated With Rhigf-1/Rhigfbp-3 for the Prevention of Retinopathy of Prematurity (Rop) Or Who Received Standard Neonatal Care NCT02386839
- Long-Term Outcome of Children Enrolled in Study Ropp-2008-01 Previously Treated With Rhigf-1Rhigfbp-3 for the Prevention of Retinopathy of Prematurity Rop Or Who Received Standard Neonatal Care NCT02386839
- Long Term Outcomes and Quality of Life Measures of EOS Patients No ClinicalTrials.gov identifier reported
- Long-term Outcomes and Resource Utilization Associated with Target vessel Failure No ClinicalTrials.gov identifier reported
- Long-Term Outcomes for Arthroscopic Circumferential Stitch Meniscus Repair vs Partial Meniscectomy using Novostitch PRO and Novocut No ClinicalTrials.gov identifier reported
- Long-Term Outcomes in Patients With Idiopathic Pulmonary Fibrosis Ipf Split By Surgical Lung Biopsy SLBX Status A Post-Hoc Analysis From the Pooled Capacity Studies No ClinicalTrials.gov identifier reported
- Long term Outcomes in PFJ Implants No ClinicalTrials.gov identifier reported
- Long term Outcomes in PFJ Implants No ClinicalTrials.gov identifier reported
- Long term Outcomes in PFJ Implants No ClinicalTrials.gov identifier reported
- Long-Term Outcomes of Dry Eye and related product No ClinicalTrials.gov identifier reported